KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Significantly Increases Spider Silk Reeling Efficiency, Boosting Per Cocoon Yield

Kraig Biocraft Laboratories Significantly Increases Spider Silk Reeling Efficiency, Boosting Per Cocoon Yield

ANN ARBOR, Mich., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has further boosted spider silk production with the introduction of new silk cocoon reeling protocols resulting in higher silk yields.



Under the guidance of renowned sericulture expert, Dr. Nirmal Kumar, the Kraig Labs production team modified the processing of its finished silk cocoons, increasing total silk yields per cocoon and improving reeling performance. These mechanical changes to the processing and handling of the Company's spider silk cocoons resulted in a near doubling of reeling efficiency compared to the prior production runs.

"Increasing processing efficiency and cocoon yield was one of Kraig's top three goals for increasing production," said Company founder and CEO, Kim Thompson. "Congratulations to the production team for these dramatic improvements. We anticipated many more months of work before seeing these results. Now we can focus on increasing individual cocoon size, and overall production volumes. I believe that even further gains in possessing yield can be achieved over the next two production cycles."

Dr. Nirmal Kumar and the Kraig Labs production team harvested the third production cycle of its proprietary spider silk cocoon last week. The BAM-1 hybrid cocoons have now been processed under the direction of Dr. Nirmal Kumar and the newly implemented enhanced protocols. In addition to finished reeling spider silk, the team has collected, analyzed, and selected the top performing BAM-1 parent line cocoons for production expansion this fall. Over the next week, selective matings of these top-performing moths will be used to create the next generation of BAM-1 parental line and BAM-1 production hybrids.

"Dr. Nirmal Kumar has evolved our operations at an incredible pace, bringing nuanced details and innovative troubleshooting that has netted outsized returns at a rapid pace," said Company COO, Jon Rice. "These small details and tweaks in processing the finished cocoons have yielded huge improvements in finished silk yield. Undoubtedly, his continued guidance will play a major role in our continuing expansion of production."

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

A photo accompany this release is available at 



EN
26/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia...

Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week New site established in collaboration with a government agency to bolster spider silk output and market readiness ANN ARBOR, Mich., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it will begin operations this week at its newest production facility. This milestone marks the launch of the first full production cycle at the site. This production site was secured earlier ...

 PRESS RELEASE

Kraig Biocraft Laboratories Sets New Production Record and Advances Sp...

Kraig Biocraft Laboratories Sets New Production Record and Advances Spider Silk Reeling with Successful Implementation of Automated Reeling Equipment Improved processing unlocks greater quality and efficiency for recombinant spider silk fiber ANN ARBOR, Mich., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the recent successful production of reeled raw recombinant spider silk using automated equipment. This batch set a new single run record, processing more than 250...

 PRESS RELEASE

Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement wit...

Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement with Government Agency in Southeast Asia to Advance Spider Silk Production ANN ARBOR, Mich., July 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the formal signing of a multi-year agreement with a government agency in Southeast Asia to support the scale-up of its recombinant spider silk production. This agreement is the result of many years of groundwork by Kraig Labs and marks a significant step in the Co...

 PRESS RELEASE

Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transi...

Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transition for Three New Spider Silk Production Strains Newly Deployed Strains Deliver Strong Performance in Initial Field Rearing Cycles, Paving the Way for Accelerated Deployment of Next-Generation Transgenics ANN ARBOR, Mich., July 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the successful completion of the first rearing cycles for its three newest recombinant spider silk production strains. These newly deve...

 PRESS RELEASE

Kraig Biocraft Laboratories Nears Strategic Three-Year Government Coll...

Kraig Biocraft Laboratories Nears Strategic Three-Year Government Collaboration to Expand Recombinant Spider Silk Production ANN ARBOR, Mich., July 18, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it is finalizing a significant three-year collaborative agreement with a key government agency in Southeast Asia to expand the scale and security of its recombinant spider silk manufacturing platform. This landmark agreement, expected to be signed before the end of July, marks the ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch